54 results on '"Chevaliez Stéphane"'
Search Results
2. FRI-431 The underestimated burden of hepatitis D among people living with chronic hepatitis B in the Gambia
3. OS-034 Safety and efficacy of REP 2139-Mg in hepatitis D patients with advanced liver disease: an international compassionate use program
4. Carcinome hépatocellulaire et virus de l’hépatite C, stratégies diagnostiques et thérapeutiques
5. Long-term outcomes of a population-based cohort of chronic hepatitis B (CHB) patients in West Africa
6. Rescue of cirrhotic HBV/HDV infection from bulevirtide failure by subcutaneous REP 2139-Mg
7. Safety and efficacy of REP 2139-Mg in association with TDF in chronic hepatitis delta patients with decompensated cirrhosis
8. Incidence of hepatitis D virus super-infection in HBsAg positive patients (The Inci-D cohort study)
9. Dried blood spot (DBS): a new tool for screening, diagnosis and monitoring of hepatitis D virus (HDV) infection
10. Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study
11. Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus
12. Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region
13. HCV-RNA viral load fingerstick assay as a simplified strategy for screening and linkage to care of people who use drugs attending 3 french addiction centers
14. Full-length genome characterization of inherently resistant african HCV genotype 1, subtype 1l in patients failing DAA-based therapy
15. Accuracy assessment of total or IgG Immunoglobulin to hepatitis A virus tests around immunity threshold.
16. Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use
17. Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region
18. Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus
19. Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use
20. Dried blood spot sampling for hepatitis C virus infection: A new tool to simplify testing algorithms
21. Diagnosis and monitoring of hepatitis C virus infection using the cobas® HCV test for use on the cobas® 4800 system
22. Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma
23. Evaluation of the Xpert HBV Viral Load for hepatitis B virus molecular testing
24. Multicenter clinical evaluation of alinity m HBV assay performance
25. In-depth molecular characterization of inherently resistant African HCV genotype 1, subtype 1l, in patients failing DAA-based therapy
26. Multicenter clinical evaluation of alinity m HCV assay performance
27. Injecting drug use during sex (known as “slamming”) among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France
28. Hepatitis C virus infection in people who inject drugs in Africa
29. The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens
30. Performance of a new rapid diagnostic test for the detection of antibodies to hepatitis C virus
31. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings
32. Performance of rapid diagnostic tests for the detection of anti-HBs in various patient populations
33. Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay
34. HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients
35. The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6 RNA
36. Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C
37. Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations
38. Is HBsAg quantification ready, for prime time?
39. Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
40. Virology of hepatitis C virus infection
41. New Virologic Tools for Management of Chronic Hepatitis B and C
42. Antiviral Activity of the new DAAs for the Treatment of Hepatitis C Virus Infection: Virology and Resistance
43. High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)
44. Nouveaux outils pour le diagnostic et le suivi des hépatites virales chroniques
45. Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: Modifications in three consecutive large surveys between 2004 and 2009
46. Virological techniques for the diagnosis and monitoring of hepatitis B and C
47. Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
48. Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells
49. Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors
50. Interferon-based therapy of hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.